Stanford Children's Health | Lucile Packard Children's Hospital Stanford’s Post

For many people with cancer, especially children, getting an intravenous (IV) line put in has often been described as the most traumatic part of their treatment. “If you think about chemotherapy, radiotherapy, surgery, vomiting, pain, the anxiety, getting sepsis, all the other things that can happen during that cancer, most patients thought having difficult IV access was the worst thing. That’s really awful and we can take that away with our service.’’ The service Ms Miller is referring to is the Fast Access and Advice for Intravenous Routes with Imaging (FAAIRI) service, which uses ultrasound techniques to ensure that needles and cannulas are inserted correctly with the very first attempt, a procedure they call ‘right line, first time’. Read the full InPractice article here 👉 https://lnkd.in/g59pWvDc

Acute Compartment Syndrome (ACS) in children on ECMO – urgent Need for Awareness! A recent study by Bridges et al. in the Journal of Pediatric Orthopaedics (March 2024) highlights a critical challenge: #ACS in children on VA #ECMO. Out of 343 pediatric patients on VA ECMO support, 5.2% developed ACS. That's more than 1 in 20! Key Findings: ▪️ Femoral artery cannulation increased ACS risk by 6 times. ▪️ #Mortality rate was a staggering 56% (10 out of 18) ▪️ Only 29% had healthy muscles at initial #fasciotomy. ▪️ Diagnosis happened 29 hours after starting ECMO, but muscle #necrosis had already begun. Are we detecting ACS too late? Can early recognition save limbs and lives? Is there a better way to detect and manage ACS in these vulnerable patients? Read the full study: https://lnkd.in/euGkNU9p Callie Shawhan, Tristen Taylor, Thomas Bini, Andrea Ontaneda, Ryan Coleman MD, Jaclyn (Rosenblum) Hill, MD, Nicole Montgomery, Vinitha Shenava, Frank Gerow #PediatricSurgery #CompartmentSyndrome #ECMO #CriticalCare #Orthopaedics #Orthopedics #EarlyDetection #SentinelpH

Dear All, Sharing this study recently published in European Journal of Cardio Thoracic Surgery (EJCTS) on behalf of my co-authors Bahaaldin Alsoufi Jaimin Trivedi  Deborah Kozik, Andrea Nicole Lambert, Joshua D Sparks. This study is one of the largest studies looking at heart transplant outcomes in Heterotaxy patients.  The study showed that Heterotaxy patients have acceptable early outcomes from survival perspective. However, they have higher risk for rejection and higher attrition at mid-term (69% survival at 5 years ) follow-up post transplantation.  There is gap in outcomes for Heterotaxy patients undergoing heart transplantation. However, the mechanism are not fully understood and overall complexity of CHD, comorbidities and unclear immunologic differences may all contribute to these outcomes. Hope you hear your thoughts, Thank you, Shri #EJCTS #pediatrichearttransplant #UNOS #outcomes #congenitalheartdisease

Want to learn more about breast health? Learn about causes, diagnoses, treatment options, and what to expect if surgery is required. Delfino Estevan Lorenzo, MD, FACS, General Surgery at South 1st Specialty & Pediatrics in Austin shares his insights into the evaluation and management of common breast disorders, including breast cancer, cysts, mastitis, and more. Empower yourself with knowledge for optimal breast health!

🌸 Exploring Pediatric Ovarian Masses: Understanding the Spectrum 🌸 In pediatric patients, ovarian masses present a diverse range of conditions, encompassing both benign and malignant tumors. These masses, specifically termed ovarian tumors, signify abnormal growths in the ovaries, varying in their nature from benign to malignant. 🟣 Benign Lesions: Common benign masses in children include simple or epithelial cysts, teratomas, and granulosa cell tumors. While typically non-cancerous, they necessitate proper evaluation and may be managed conservatively with surgical approaches to preserve function. 🟣 Malignant Tumors: Though less frequent, malignant ovarian tumors in children pose greater concern due to their potential for spreading to other organs. They encompass germ cell tumors, epithelial cell tumors, stromal cell tumors, or metastatic lesions, requiring aggressive treatment modalities like surgery, chemotherapy, or radiation. 🔍 Diagnosis: Accurate differentiation between benign and malignant masses is pivotal for determining appropriate management strategies. While ultrasound aids in initial identification, further evaluation through imaging studies and tumor markers is often indispensable. The intricate balance between diagnosis and treatment underscores the importance of a multidisciplinary approach in pediatric ovarian masses. Let's continue the conversation and share our insights on optimizing care for these young patients. #PediatricOvarianMasses #OvarianTumors #ChildhoodCancerAwareness #PediatricOncology

If you feel a lump during a self-breast exam or get a call that something was spotted on your latest mammogram, your first thought may be, ‘It’s cancer.’ Yes, breast cancer is one of the leading cancer diagnoses in women. But there’s no need for immediate panic. You could have a benign breast condition that is not life-threatening and is not cancer. Generally speaking, benign breast disease is a group of conditions that involve breast changes that are not malignant. These changes can be found on imaging, felt during self-breast exams or discovered following breast discomfort. Benign breast disease is very common. In fact, the team at Telfair Breast Surgery at St. Joseph’s/Candler sees more benign breast conditions than cancer, says Candace Walton, nurse practitioner at Telfair Breast Surgery. “Normally, it starts with imaging, Sometimes it does start with generalized breast pain or they feel a mass,” Walton says. “A lot of patients may have their first mammogram that shows something in their breast that’s been there for a long time, and they just didn’t know it. It gets flagged, such as a cyst, but a large majority of them are benign cysts.” Walton lists some of the more common conditions of benign breast disease: https://lnkd.in/e5BS2MMV #benignbreastdisease #breasthealth #mammograms #mammogram #mammography #nurse #nursepractitioner #nursesoflinkedin #nurses #breastcancer #breastcancerawareness #breastselfexam

My #MotivationMonday starts with what gets me going everyday, my two sons. My oldest was born with a congenital heart defect called Truncus Arteriosus, requiring multiple surgeries and interventions over a lifetime. Bringing pediatric innovation to the forefront isn't just good business. For me, it's personal. I was fortunate to catch Kayleen Brown’s interview panel at DeviceTalks West 2023 discussing the unique complexities and challenges of #pediatric device development. Her article linked below is a succinct summary of important points when assessing this growth market. Greatest challenges: - Miniaturization, with growth potential (babies hearts are the size of a walnut, growing to the size of a hand by 18 years old) -Durability, with safe, effective biomaterials -Safety consideration beyond standard (neurodevelopmental, excessive radiation exposure, vascular preservation) Greatest opportunities: - The growth of a hybrid OR, where surgery and interventions can happen together, is positive momentum for treatment -Expanded focus into #mitral, #tricuspid and #pulmonary valve work is only elevating future possibilities for the youngest patients There is so much great work to be done in our industry. Thanks for the article, Kayleen. Medical Design & Outsourcing #FebruaryHeartMonth #HeartMonth #Heartmonth2024 #CHD #chdawareness #pediatriccardiology #themullingsgroup #medtech

🌟 Exciting News from the 4th Annual Meeting of the Asian Association for Pediatric and Congenital Heart Surgery (AAPCHS)! 🌟 From May 31 to June 1, 2024, over 200 experts, researchers, and clinicians from 16 countries gathered in Seoul, South Korea, to discuss the latest advancements in congenital heart disease. This prestigious event provided new perspectives and insights, significantly impacting the congenital heart disease community. A highlight of the meeting was the strengthened collaboration between the Congenital Heart Disease (CHD) journal and AAPCHS. Prof. Xuming Mo and Prof. Hao Zhang engaged in fruitful discussions with AAPCHS President, Prof. Kisaburo Sakamoto, proposing CHD as the official journal of AAPCHS. This initiative aims to provide a platform for high-quality research and expand CHD's global influence. Key topics included innovative surgical techniques, the application of 3D models, and groundbreaking research in congenital heart disease treatment. We are excited about this partnership and its potential to enhance research visibility and foster innovation. Together, we strive to improve patient outcomes and advance the field of congenital heart disease. Read more: https://lnkd.in/gcyd6k2d #AAPCHS2024 #CongenitalHeartDisease #CHDJournal #MedicalResearch #PediatricCardiology #GlobalHealth #InnovationInMedicine

Stereoelectroencephalography and surgical treatment of TSC-associated epilepsy in children: preliminary results The most prevalent symptom of central nervous system involvement in tuberous sclerosis complex is epilepsy, predominantly of a drug-resistant nature. In such cases, surgical treatment methods become a focal point for consideration. Purpose of the study: to analyze the outcomes of surgical treatment for drug-resistant epilepsy in children with tuberous sclerosis following stereoelectroencephalography. A retrospective analysis of surgical outcomes for epilepsy in children with tuberous sclerosis after stereo-EEG was conducted. From April 2017 to December 2021, 23 patients underwent prolonged stereo-EEG monitoring. Based on the results of invasive EEG, resective surgery was performed on 14 patients. Primary resection of the epileptogenic zone was carried out in 11 cases (79 %), and repeated resection was performed in 3 cases (21 %). Tuberectomy was conducted in three cases, tuberectomy plus — in six patients, lobectomy — in three patients, multilobar resection — in three cases, and one patient had an extension of the previous resection area with corticoectomy. Results. In the follow-up period ranging from 12 to 78 months, ILAE I outcome was observed in 64 % of cases, ILAE IV in 29 % of children, and ILAE V in 7 % of cases. Antiepileptic therapy was discontinued in one patient, a decrease in drug load was noted in four patients, and an increase in drug load was observed in one patient. https://lnkd.in/eakHRQvY

New research in JAMA Surgery explores the timing of whole blood transfusion. In a cohort study of patients with severe traumatic hemorrhage who required massive transfusion, a reduction in time to first whole blood transfusion was associated with survival benefits. https://bit.ly/3Snz5OP #WholeBlood #TransfusionMedicine #CriticalCare #Transfusion